| Literature DB >> 34990969 |
Xiaolan Li1, Zhi-Hong Zhang1, Jiaqi Qiao1, Wenjuan Qu1, Man-Sheng Wang2, Xianli Gao1, Cunsheng Zhang3, Charles S Brennan4, Xianghui Qi5.
Abstract
Natural betalains can be potential food additives because of their antioxidant activities, but they have poor thermal stability. In this study, betalains were extracted from red dragon fruit peel, and then encapsulated with maltodextrin by ultrasound method to increase the physicochemical properties of betalains microcapsules. The encapsulation efficiency of the betalains was above 79%, and the particle size and Zeta potential values were 275.46 nm and -29.01 mV, respectively. Compared to the control sample, onset temperature and DPPH free radical scavenging of betalains microcapsules under the modest ultrasound treatment (200 W, 5 min) was increased by 1.6 °C and 12.24%, respectively. This increase could be due to the ability of ultrasonification to create interactions between maltodextrin and betalains (as evidenced by FT-IR). Therefore, modest ultrasound treatment can be used for microcapsulation to improve the stability of betalains, and then expand the application of betalains in heat processed food field.Entities:
Keywords: Betalains; Maltodextrin; Physicochemical properties; Red dragon fruit peel; Ultrasound treatment
Mesh:
Substances:
Year: 2021 PMID: 34990969 PMCID: PMC8799603 DOI: 10.1016/j.ultsonch.2021.105897
Source DB: PubMed Journal: Ultrason Sonochem ISSN: 1350-4177 Impact factor: 7.491
Ultrasound-assisted preparation of betalains microencapsulates parameters.
| Samples | Ultrasound power (W) | Ultrasound time (min) |
|---|---|---|
| Control | 0 | 0 |
| BM1/5 | 100 | 5 |
| BM2/5 | 200 | 5 |
| BM3/5 | 300 | 5 |
| BM4/5 | 400 | 5 |
| BM2/1 | 200 | 1 |
| BM2/2 | 200 | 2 |
| BM2/5 | 200 | 5 |
| BM2/10 | 200 | 10 |
Fig. 1The concentration of betacyanin and betaxanthin in the extraction solution after prolonged heating time at 60 °C (different letters represent the different significantly (p < 0.05)).
Fig. 2The encapsulation efficiency (EE) of betalains under different ultrasound treatment (different letters represent the different significantly (p < 0.05)).
The microcapsules size distribution and Zeta potential of betalains microcapsules at the different ultrasound treatment
| Samples | Microcapsules size distribution (nm) | Zeta potential value (mV) |
|---|---|---|
| Control | 409.45 ± 19.39a | −14.58 ± 2.18b |
| BM1/5 | 300.77 ± 7.35 cd | −8.11 ± 2.40b |
| BM2/5 | 275.46 ± 20.68d | −29.01 ± 1.74a |
| BM3/5 | 307.03 ± 8.93c | −23.81 ± 3.70a |
| BM4/5 | 311.56 ± 10.36c | −25.58 ± 1.58a |
| BM2/1 | 357.26 ± 9.02b | −13.26 ± 2.52bc |
| BM2/2 | 313.08 ± 9.01c | −12.82 ± 2.11bc |
| BM2/10 | 352.28 ± 6.58b | −17.61 ± 4.31b |
Different superscript letters represent the significant differences in the same column (p < 0.05)
Fig. 3The morphology of betalains microcapsules by different ultrasound treatment (×1000).
Fig. 4FT-IR of betalains microcapsules by different ultrasound treatment.
Fig. 5The results of DSC of betalains microcapsules by different ultrasound treatment.
Fig. 6DPPH free radical scavenging activity of betalains microcapsules by different ultrasound treatment (different letters represent the different significantly (p < 0.05)).